Skip to content

An investigation of the safety and efficacy of robot-assisted laparoscopic surgery for cervical and uterine cancer

An investigation of the safety and efficacy of robot-assisted laparoscopic surgery for cervical and uterine cancer - Robot-assisted laparoscopic surgery for cervical and uterine cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013229
Enrollment
10
Registered
2014-03-01
Start date
2014-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer and uterine cancer

Interventions

Patients with cervical cancer or uterine cancer, who are eligible for radical surgery and provide voluntary consent by signing the written informed consent documents, will undergo robot-assisted radic

Sponsors

Department of Gynecology, Hokkaido University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women who are 20 years old at the time of giving informed consent. 2. Patient with clinical stage I – II cervical cancer or patients who are supposed to have surgical stage I – III uterine cancer (cervical cancer is staged before treatment and uterine cancer is staged after surgery by histo-pathological examination). 3.PS: 0 – 1 4. Patients who have been given information and who have discussed the risks, benefits and other aspects of the trial with principal investigator and who provide voluntary consent by signing the written informed consent documents.

Exclusion criteria

Exclusion criteria: 1. Patient with cervical or uterine cancer with specific subtype of undifferentiated carcinoma, small cell carcinoma, clear cell adenocarcinoma, glassy cell carcinoma. 2. Patients who are judged to be not eligible for the study.

Design outcomes

Primary

MeasureTime frame
Operation time, console time, blood loss, intra-operative/post-operative complications will be recorded, which will be compared to those of open surgery for cervical and uterine cancers.

Secondary

MeasureTime frame
Histopathological completeness of surgery, number of lymph nodes harvested, post-operative bladder function, 5-year recurrence free survival and the site of recurrence.

Countries

Japan

Contacts

Public ContactNoriaki Sakuragi

Hokkaido University Graduate School of Medicine Department of Gynecology

sakuragi@med.hokudai.ac.jp011-706-5938

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026